However, we can speculate that in a population of morbid obese patients, where adiponectin levels are already extremely low and associated with NAFLD, the correlation with more severe disease such as NASH is weakened. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.